AKILOS

This brand name is authorized in Nigeria.

Active ingredients

The drug AKILOS contains one active pharmaceutical ingredient (API):

`1`	Aceclofenac UNII `RPK779R03H` - ACECLOFENAC
	Aceclofenac is a non-steroidal agent with marked anti-inflammatory and analgesic properties. The mode of action of aceclofenac is largely based on the inhibition to prostaglandin synthesis. Aceclofenac is a potent inhibitor of the enzyme cyclo-oxygenase, which is involved in the production of prostaglandins.
	Read more about Aceclofenac

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
C4-1740	Tablet	Akilos-CR Tablets TAB 200 mg 1 x 10's (in Alu-PVC/PVDC blister)	Film coated tablets. White to off white, round, biconvex film-coated tablets, plain on both sides	24/06/2021

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	C4-1740

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.